Solara Active Pharma Sciences Limited (NSE:SOLARA)
India flag India · Delayed Price · Currency is INR
611.00
-8.05 (-1.30%)
Oct 23, 2026, 1:50 PM IST

NSE:SOLARA Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
15,35213,69012,83812,88914,43812,683
Revenue Growth
27.30%6.64%-0.40%-10.73%13.84%-21.56%
Gross Profit
6,9266,3606,2314,2616,0495,605
Operating Income
1,299881.41,081-1,975275.9-259.9
Net Income
369.4-74.15.4-5,674-221.8-581.5
Earnings Per Share
7.99-1.680.14-148.51-6.16-16.18
EPS Growth
310.02%-----

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
709.174.839.584.487.3463.8
Total Debt
5,9136,8667,96110,11510,12910,374
Net Cash (Debt)
-5,204-6,791-7,921-10,031-10,041-9,910
Net Cash Growth
------
Net Cash Per Share
-112.51-154.10-198.52-262.55-278.95-275.72

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
1,4221,5292,1281,0891,563-2,420
Capital Expenditures
-790.5-528.2-399.4-410.6-1,113-2,086
Free Cash Flow
631.41,0011,729678.1449.4-4,507
Free Cash Flow Growth
-54.26%-42.10%154.95%50.89%--

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
45.11%46.45%48.54%33.06%41.90%44.19%
Operating Margin
8.46%6.44%8.42%-15.33%1.91%-2.05%
Pretax Margin
2.41%-0.54%0.04%-37.89%-3.10%-7.18%
Profit Margin
2.41%-0.54%0.04%-44.02%-1.54%-4.58%
FCF Margin
4.11%7.31%13.47%5.26%3.11%-35.53%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
76.51-4566.82---
Forward PE
-13.0917.8027.2533.3322.46
P/FCF Ratio
47.3020.4814.2719.6926.23-
PS Ratio
1.951.501.921.040.821.89